115 related articles for article (PubMed ID: 27764814)
1. Downregulation of osteoprotegerin expression in metastatic colorectal carcinoma predicts recurrent metastasis and poor prognosis.
Moon A; Do SI; Kim HS; Kim YW
Oncotarget; 2016 Nov; 7(48):79319-79326. PubMed ID: 27764814
[TBL] [Abstract][Full Text] [Related]
2. Down-regulation of osteoprotegerin expression as a novel biomarker for colorectal carcinoma.
Kim HS; Yoon G; Do SI; Kim SJ; Kim YW
Oncotarget; 2016 Mar; 7(12):15187-99. PubMed ID: 26942563
[TBL] [Abstract][Full Text] [Related]
3. Downregulation of Mus81 as a novel prognostic biomarker for patients with colorectal carcinoma.
Wu F; Shirahata A; Sakuraba K; Kitamura Y; Goto T; Saito M; Ishibashi K; Kigawa G; Nemoto H; Sanada Y; Hibi K
Cancer Sci; 2011 Feb; 102(2):472-7. PubMed ID: 21175991
[TBL] [Abstract][Full Text] [Related]
4. Reduced Raf-1 kinase inhibitor protein expression predicts less favorable outcomes in patients with hepatic colorectal metastasis.
Kim HS; Park SJ; Lee KY; Park YK; Kim YW
Oncol Rep; 2012 Jul; 28(1):161-71. PubMed ID: 22562283
[TBL] [Abstract][Full Text] [Related]
5. Stromal cell derived factor-1 and CXCR4 expression in colorectal cancer promote liver metastasis.
Amara S; Chaar I; Khiari M; Ounissi D; Weslati M; Boughriba R; Hmida AB; Bouraoui S
Cancer Biomark; 2015; 15(6):869-79. PubMed ID: 26406413
[TBL] [Abstract][Full Text] [Related]
6. CPEB4 immunohistochemical expression is associated to prognosis in stage IV colorectal carcinoma.
Cortés-Guiral D; Pastor-Iodate C; Díaz Del Arco C; Del Puerto-Nevado L; Fernández-Aceñero MJ
Pathol Res Pract; 2017 Jun; 213(6):639-642. PubMed ID: 28551384
[TBL] [Abstract][Full Text] [Related]
7. Global histone modification of H3K27 correlates with the outcomes in patients with metachronous liver metastasis of colorectal cancer.
Tamagawa H; Oshima T; Numata M; Yamamoto N; Shiozawa M; Morinaga S; Nakamura Y; Yoshihara M; Sakuma Y; Kameda Y; Akaike M; Yukawa N; Rino Y; Masuda M; Miyagi Y
Eur J Surg Oncol; 2013 Jun; 39(6):655-61. PubMed ID: 23523318
[TBL] [Abstract][Full Text] [Related]
8. CD44v6 down-regulation is an independent prognostic factor for poor outcome of colorectal carcinoma.
Wang L; Liu Q; Lin D; Lai M
Int J Clin Exp Pathol; 2015; 8(11):14283-93. PubMed ID: 26823744
[TBL] [Abstract][Full Text] [Related]
9. Nuclear aldehyde dehydrogenase 1A1 (ALDH1A1) expression is a favorable prognostic indicator in colorectal carcinoma.
Wang L; Lin D; Fu Y; Lai M
Pathol Res Pract; 2016 Sep; 212(9):791-9. PubMed ID: 27461829
[TBL] [Abstract][Full Text] [Related]
10. [Expression of phosphatase of regeneration liver-3 in human colorectal carcinoma and its prognosis value].
Zhao GP; Zhou ZG; Lei WZ; Wang C; Zheng XL; Zheng YC
Zhonghua Wei Chang Wai Ke Za Zhi; 2008 Sep; 11(5):487-91. PubMed ID: 18803057
[TBL] [Abstract][Full Text] [Related]
11. nm23 protein expression in colorectal carcinoma metastasis in regional lymph nodes and the liver.
Sarris M; Lee CS
Eur J Surg Oncol; 2001 Mar; 27(2):170-4. PubMed ID: 11289754
[TBL] [Abstract][Full Text] [Related]
12. PLK-1 Expression is Associated with Histopathological Response to Neoadjuvant Therapy of Hepatic Metastasis of Colorectal Carcinoma.
Fernández-Aceñero MJ; Cortés D; Gómez del Pulgar T; Cebrián A; Estrada L; Martínez-Useros J; Celdrán A; García-Foncillas J; Pastor C
Pathol Oncol Res; 2016 Apr; 22(2):377-83. PubMed ID: 26577686
[TBL] [Abstract][Full Text] [Related]
13. Expression of adhesion molecules in hepatic metastases of colorectal carcinoma: relationship to primary tumours and prognosis after hepatic resection.
Nanashima A; Yamaguchi H; Sawai T; Yasutake T; Tsuji T; Jibiki M; Yamaguchi E; Nakagoe T; Ayabe H
J Gastroenterol Hepatol; 1999 Oct; 14(10):1004-9. PubMed ID: 10530497
[TBL] [Abstract][Full Text] [Related]
14. DNA hydroxymethylation of colorectal primary carcinoma and its association with survival.
Zhong A; Tian Y; Zhang H; Lai M
J Surg Oncol; 2018 Apr; 117(5):1029-1037. PubMed ID: 29529342
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of beta-catenin in colorectal cancer with liver metastasis.
Han SA; Chun H; Park CM; Kang SJ; Kim SH; Sohn D; Yun SH; Lee WY
Clin Oncol (R Coll Radiol); 2006 Dec; 18(10):761-7. PubMed ID: 17168211
[TBL] [Abstract][Full Text] [Related]
16. Downregulated P1 promoter-driven hepatocyte nuclear factor-4alpha expression in human colorectal carcinoma is a new prognostic factor against liver metastasis.
Oshima T; Kawasaki T; Ohashi R; Hasegawa G; Jiang S; Umezu H; Aoyagi Y; Iwanari H; Tanaka T; Hamakubo T; Kodama T; Naito M
Pathol Int; 2007 Feb; 57(2):82-90. PubMed ID: 17300672
[TBL] [Abstract][Full Text] [Related]
17. CD146 protein as a marker to predict postoperative liver metastasis in colorectal cancer.
Tian B; Zhang Y; Li N
Cancer Biother Radiopharm; 2013; 28(6):466-70. PubMed ID: 23745687
[TBL] [Abstract][Full Text] [Related]
18. Expression of prokineticin-receptor2(PK-R2) is a new prognostic factor in human colorectal cancer.
Goi T; Kurebayashi H; Ueda Y; Naruse T; Nakazawa T; Koneri K; Hirono Y; Katayama K; Yamaguchi A
Oncotarget; 2015 Oct; 6(31):31758-66. PubMed ID: 26372733
[TBL] [Abstract][Full Text] [Related]
19. DDX3 as a strongest prognosis marker and its downregulation promotes metastasis in colorectal cancer.
Su CY; Lin TC; Lin YF; Chen MH; Lee CH; Wang HY; Lee YC; Liu YP; Chen CL; Hsiao M
Oncotarget; 2015 Jul; 6(21):18602-12. PubMed ID: 26087195
[TBL] [Abstract][Full Text] [Related]
20. Colon cancer stem cell markers CD44 and CD133 in patients with colorectal cancer and synchronous hepatic metastases.
Jing F; Kim HJ; Kim CH; Kim YJ; Lee JH; Kim HR
Int J Oncol; 2015 Apr; 46(4):1582-8. PubMed ID: 25625240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
